Evidence map›Paper›PMID 37705728›Full record

ArticlePhysics and imaging in radiation oncology2023

Early clinical experience with a degraded 4 MeV electron beam in radiotherapy of superficial basal cell carcinoma.

Assi Valve, Sari Koskenmies, Mikko Tenhunen, Heidi Nurmi, Micaela Hernberg, Samuli Salminen, Anu Anttonen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physics and imaging in radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Assi ValveCancer Center, Department of Radiation Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Sari KoskenmiesDepartment of Dermatology and Allergology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Mikko TenhunenCancer Center, Department of Radiation Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Heidi NurmiDepartment of Oncology, Turku University Hospital, Turku, Finland.
Micaela HernbergCancer Center, Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Samuli SalminenCancer Center, Department of Radiation Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Anu AnttonenCancer Center, Department of Radiation Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common non-melanoma skin cancer is basal cell carcinoma (BCC). Surgery is the gold standard treatment but also non-surgical alternatives are needed. The purpose of this work was to present the early clinical experiences of degraded 4 MeV electron beam as a treatment method for superficial BCC. Twelve patients underwent two weeks radiation therapy treatment with either 5 × 7 Gy or 2 × 12 Gy. There were no significant differences in treatment outcome with different fractionations or lesion locations. The degraded beam method is a safe and valid non-surgical solution for suitable patients with superficial lesions.

Indexed as

Clinical trialElectron beamSkin cancer

Identifiers

PMID37705728
PMCPMC10495663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.